Login
$BLTE
$162.56 -$1.79 (1.09%) Live

$BLTE 4 SEC Filings

Filed On Filing
16 Nov 2026 Form 4: Scholl Hendrik Peter, Chief Medical Officer

Sold 2,000 shares ($332K)

30 Oct 2026 Form 4: Chuang Hao-Yuan, Director

Acquired 5,000 shares (Other Transaction)

30 Oct 2026 Form 4: Lin Yu-Hsin, Director

Acquired 5,000 shares (Other Transaction)

30 Oct 2026 Form 4: Chen Wan-Shan, Director

Received 13,796 shares by exercise ($6.05K)

05 Oct 2026 Form 4: Scholl Hendrik Peter, Chief Medical Officer

Sold 500 shares ($82.7K)

09 Sep 2026 Form 4: Lin Yu-Hsin, Director

Sold 74,435 shares ($14M) · Sold 26,000 shares ($5.11M)

09 Sep 2026 Form 4: Chuang Hao-Yuan, Director

Sold 49,433 shares ($9.28M) · Sold 17,962 shares ($3.53M)

14 Aug 2026 Form 4: Chuang Hao-Yuan, Director

Sold 367 shares ($66.2K)

14 Aug 2026 Form 4: Lin Yu-Hsin, Director

Sold 365 shares ($65.8K)

22 Jun 2026 Form 4: Scholl Hendrik Peter, Chief Medical Officer

Sold 10,000 shares ($1.45M)

17 Jun 2026 Form 4: Scholl Hendrik Peter, Chief Medical Officer

Sold 10,000 shares ($1.41M)

08 May 2026 Form 4: Mata Nathan L., Chief Scientific Officer

Sold 666 shares ($102K)

07 May 2026 Form 4: Mata Nathan L., Chief Scientific Officer

Sold 1,000 shares ($154K)

06 May 2026 Form 4: Mata Nathan L., Chief Scientific Officer

Sold 1,000 shares ($156K)

05 May 2026 Form 4: Mata Nathan L., Chief Scientific Officer

Sold 1,000 shares ($156K)

04 May 2026 Form 4: Mata Nathan L., Chief Scientific Officer

Sold 1,000 shares ($156K)

01 May 2026 Form 4: Mata Nathan L., Chief Scientific Officer

Sold 1,000 shares ($157K)

30 Apr 2026 Form 4: Mata Nathan L., Chief Scientific Officer

Sold 1,000 shares ($156K)

29 Apr 2026 Form 4: Mata Nathan L., Chief Scientific Officer

Sold 1,000 shares ($159K)

28 Apr 2026 Form 4: Mata Nathan L., Chief Scientific Officer

Sold 1,000 shares ($163K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support